Showing results (1631-1640 of 1,704) with videos related to
Sort By:
Pageof 171
Journal of the American College of Cardiology|July 1, 2026
Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle BiologyMihir M Sanghvi, Hannah L Nicholls, Thomas M Kaplan, et al.Cellular and Molecular Gastroenterology and Hepatology|November 1, 2016
Interleukin 10 Restores Gastric Emptying, Electrical Activity, and Interstitial Cells of Cajal Networks in Diabetic MiceKyoung Moo Choi, Simon J Gibbons, Lei Sha, et al.Clinical Nutrition (Edinburgh, Scotland)|October 15, 2021
Current perspectives on defining and mitigating frailty in relation to critical illnessN A Costa, M F Minicucci, A G Pereira, et al.BMC Proceedings|March 1, 2026
Rebuilding the foundation: recommendations from the Summit to Revitalize Primary Care (Rev PC), Anthony Jerant, Richard L Kravitz, et al.Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|July 6, 2026
LARGE-SCALE DISEASE-ASSOCIATED MORTALITY EVENT OF EASTERN BOX TURTLES (TERRAPENE CAROLINA CAROLINA) CONFISCATED DUE TO THE ILLEGAL WILDLIFE TRADEMaris J Daleo, Charles J Innis, Laura A Adamovicz, et al.Abdominal Radiology (New York)|September 22, 2022
Inter- and intra-observer variability of computed tomography-based parenchymal- and ductal diameters in chronic pancreatitis: a multi-observer international studyJens Borgbjerg, Emily Steinkohl, Søren S Olesen, et al.Journal of Medicinal Chemistry|November 7, 2000
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptorG Mullen, J Napier, M Balestra, et al.The American Journal of Pathology|June 14, 2013
Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosisXiaoyan Tang, Ruoqi Peng, Jonathan E Phillips, et al.Cancer|February 11, 2014
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatmentMatthew J Resnick, Daniel A Barocas, Alicia K Morgans, et al.Plos Neglected Tropical Diseases|May 30, 2017
Optimising cluster survey design for planning schistosomiasis preventive chemotherapySarah C L Knowles, Hugh J W Sturrock, Hugo Turner, et al.Pageof 171